Apr 23 |
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
|
Apr 22 |
With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
|
Apr 22 |
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
|
Apr 21 |
11 Best Low Price Pharma Stocks To Invest In
|
Apr 19 |
20 Countries with the Highest Cancer Survival Rates in the World
|
Apr 18 |
Astrazeneca (AZN) Could Be a Great Choice
|
Apr 16 |
IMFINZI® (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial
|
Apr 15 |
3 Pharma Stocks That Are Money-Printing Machines in 2024
|
Apr 14 |
4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
|
Apr 12 |
AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids
|